Organoids and Organs-on-chips: Insights into Predicting the Efficacy of Systemic Treatment in Colorectal Cancer

Overview

Journal Cell Death Discov

Date 2023 Feb 22

PMID 36813783

Authors

Jialong Zhu

Linlin Ji

Yitian Chen

Huiyu Li

Mengxi Huang

Zhe Dai

Jing Wang

Dan Xiang

Gongbo Fu

Zengjie Lei

Xiaoyuan Chu

Affiliations

Soon will be listed here.

Abstract

Cancer heterogeneity has posed a great challenge to traditional cancer treatment, with the reappearance of cancer heterogeneity of inter and intra patients being especially critical. Based on this, personalized therapy has emerged as significant research focus in recent and even future years. Cancer-related therapeutic models are developing, including cell lines, patient-derived xenografts, organoids, etc. Organoids are three-dimensional in vitro models emerged in the past dozen years and are able to reproduce the cellular and molecular composition of the original tumor. These advantages demonstrate the great potential for patient-derived organoids to develop personalized anticancer therapies, including preclinical drug screening and the prediction of patient treatment response. The impact of microenvironment on cancer treatment cannot be underestimated, and the remodeling of microenvironment also allows organoids to interact with other technologies, among which organs-on-chips is a representative one. This review highlights the use of organoids and organs-on-chips as complementary reference tools in treating colorectal cancer from the perspective of clinical efficacy predictability. We also discuss the limitations of both techniques and how they complement each other well.

Citing Articles

Hsa-miR-526b-5p Regulates the Sensitivity of Colorectal Cancer to 5-Fluorouracil by Targeting TP53 in Organoid Models.

Huang L, Liao C, Xiong Z, Chen Z, Zhang S Biochem Genet. 2025; .

PMID: 39953363 DOI: 10.1007/s10528-025-11045-y.

A microfluidics platform for simultaneous evaluation of sensitivity and side effects of anti-cancer drugs using a three-dimensional culture method.

Kobayashi Y, Hashizume H, Takiguchi S, Ji J, Kawano R, Koiwai K Sci Rep. 2025; 15(1):39.

PMID: 39747285 PMC: 11697305. DOI: 10.1038/s41598-024-84297-0.

Advances in the application of colorectal cancer organoids in precision medicine.

Zhang Y, Meng R, Sha D, Gao H, Wang S, Zhou J Front Oncol. 2024; 14:1506606.

PMID: 39697234 PMC: 11653019. DOI: 10.3389/fonc.2024.1506606.

Challenges in validation of combination treatment strategies for CRC using patient-derived organoids.

Benboubker V, Ramzy G, Jacobs S, Nowak-Sliwinska P J Exp Clin Cancer Res. 2024; 43(1):259.

PMID: 39261955 PMC: 11389238. DOI: 10.1186/s13046-024-03173-x.

Organs on chips: fundamentals, bioengineering and applications.

Awad N J Artif Organs. 2024; .

PMID: 39134691 DOI: 10.1007/s10047-024-01460-0.

References

Sontheimer-Phelps A, Hassell B, Ingber D . Modelling cancer in microfluidic human organs-on-chips. Nat Rev Cancer. 2019; 19(2):65-81. DOI: 10.1038/s41568-018-0104-6. View

Drost J, Clevers H . Organoids in cancer research. Nat Rev Cancer. 2018; 18(7):407-418. DOI: 10.1038/s41568-018-0007-6. View

Tao T, Wang Y, Chen W, Li Z, Su W, Guo Y . Engineering human islet organoids from iPSCs using an organ-on-chip platform. Lab Chip. 2019; 19(6):948-958. DOI: 10.1039/c8lc01298a. View

Carvalho M, Barata D, Teixeira L, Giselbrecht S, Reis R, Oliveira J . Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine. Sci Adv. 2019; 5(5):eaaw1317. PMC: 6531003. DOI: 10.1126/sciadv.aaw1317. View

Demmers L, Kretzschmar K, Van Hoeck A, Bar-Epraim Y, van den Toorn H, Koomen M . Single-cell derived tumor organoids display diversity in HLA class I peptide presentation. Nat Commun. 2020; 11(1):5338. PMC: 7577990. DOI: 10.1038/s41467-020-19142-9. View

Gao D, Vela I, Sboner A, Iaquinta P, Karthaus W, Gopalan A . Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014; 159(1):176-187. PMC: 4237931. DOI: 10.1016/j.cell.2014.08.016. View

Huch M, Gehart H, van Boxtel R, Hamer K, Blokzijl F, Verstegen M . Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell. 2014; 160(1-2):299-312. PMC: 4313365. DOI: 10.1016/j.cell.2014.11.050. View

Xiao L, Cen D, Gan H, Sun Y, Huang N, Xiong H . Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients. Mol Ther. 2019; 27(6):1114-1125. PMC: 6554529. DOI: 10.1016/j.ymthe.2019.03.011. View

Zhang C, Wang Z, Yang Z, Wang M, Li S, Li Y . Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA Metastatic Colorectal Cancers. Mol Ther. 2017; 25(5):1248-1258. PMC: 5417843. DOI: 10.1016/j.ymthe.2017.03.010. View

10.

Glieberman A, Pope B, Zimmerman J, Liu Q, Ferrier J, Kenty J . Synchronized stimulation and continuous insulin sensing in a microfluidic human Islet on a Chip designed for scalable manufacturing. Lab Chip. 2019; 19(18):2993-3010. PMC: 6814249. DOI: 10.1039/c9lc00253g. View

11.

Schutgens F, Rookmaaker M, Margaritis T, Rios A, Ammerlaan C, Jansen J . Tubuloids derived from human adult kidney and urine for personalized disease modeling. Nat Biotechnol. 2019; 37(3):303-313. DOI: 10.1038/s41587-019-0048-8. View

12.

Mullenders J, de Jongh E, Brousali A, Roosen M, Blom J, Begthel H . Mouse and human urothelial cancer organoids: A tool for bladder cancer research. Proc Natl Acad Sci U S A. 2019; 116(10):4567-4574. PMC: 6410883. DOI: 10.1073/pnas.1803595116. View

13.

Lee S, Hu W, Matulay J, Silva M, Owczarek T, Kim K . Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer. Cell. 2018; 173(2):515-528.e17. PMC: 5890941. DOI: 10.1016/j.cell.2018.03.017. View

14.

Monteiro M, Zhang Y, Gaspar V, Mano J . 3D-bioprinted cancer-on-a-chip: level-up organotypic in vitro models. Trends Biotechnol. 2021; 40(4):432-447. PMC: 8916962. DOI: 10.1016/j.tibtech.2021.08.007. View

15.

Hassell B, Goyal G, Lee E, Sontheimer-Phelps A, Levy O, Chen C . Human Organ Chip Models Recapitulate Orthotopic Lung Cancer Growth, Therapeutic Responses, and Tumor Dormancy In Vitro. Cell Rep. 2017; 21(2):508-516. DOI: 10.1016/j.celrep.2017.09.043. View

16.

Sellgren K, Butala E, Gilmour B, Randell S, Grego S . A biomimetic multicellular model of the airways using primary human cells. Lab Chip. 2014; 14(17):3349-58. DOI: 10.1039/c4lc00552j. View

17.

Sato T, Vries R, Snippert H, van de Wetering M, Barker N, Stange D . Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009; 459(7244):262-5. DOI: 10.1038/nature07935. View

18.

Biller L, Schrag D . Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA. 2021; 325(7):669-685. DOI: 10.1001/jama.2021.0106. View

19.

Palikuqi B, Nguyen D, Li G, Schreiner R, Pellegata A, Liu Y . Adaptable haemodynamic endothelial cells for organogenesis and tumorigenesis. Nature. 2020; 585(7825):426-432. PMC: 7480005. DOI: 10.1038/s41586-020-2712-z. View

20.

Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C . Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006; 313(5795):1960-4. DOI: 10.1126/science.1129139. View